Study of SPR001 in Adults With Classic Congenital Adrenal Hyperplasia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Richard Auchus, MD, PhD
University of Michigan
Principal Investigator - Spruce Chief Medical Officer, MD
Spruce Biosciences
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Spruce Biosciences Clinical Site
Orange, California, United States
- Spruce Biosciences Clinical Site
San Diego, California, United States
- Spruce Biosciences Clinical Site
Melbourne, Florida, United States
- Spruce Biosciences Clinical Site
Atlanta, Georgia, United States
- Spruce Biosciences Clinical Site
Indianapolis, Indiana, United States
- Spruce Biosciences Clinical Site
Ann Arbor, Michigan, United States
- Spruce Biosciences Clinical Site
Minneapolis, Minnesota, United States
- Spruce Biosciences Clinical Site
Las Vegas, Nevada, United States
- Spruce Biosciences Clinical Site
Philadelphia, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Jul 2017
- Primary completion
- 2 Mar 2019
- Completion
- 29 Mar 2019
- Last update posted
- 22 Oct 2025
- Registered enrollment
- 24
- Registry id
- NCT03257462
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.